Quarterly report pursuant to Section 13 or 15(d)
Cover
Document And Entity Information
Financial Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (Parentheticals)
Consolidated Statements of Operations (Unaudited)
Consolidated Statements of Comprehensive Income (Loss) (Unaudited)
Consolidated Statements of Stockholders??? Equity (Unaudited)
Consolidated Statements of Cash Flows (Unaudited)
Notes to Financial Statements
Basis of Presentation
Net income (loss) per share
Revenue Recognition
Supplemental Disclosure for Statement of Cash Flows
Inventories
Goodwill and intangible assets
Long term debt
Leases
Accrued Liabilities
Stockholders??? Equity
Segment reporting
Contingencies
Subsequent Events
Accounting Policies
Accounting Policies, by Policy (Policies)
Notes Tables
Revenue Recognition (Tables)
Inventories (Tables)
Goodwill and intangible assets (Tables)
Long term debt (Tables)
Leases (Tables)
Accrued Liabilities (Tables)
Stockholders??? Equity (Tables)
Segment reporting (Tables)
Notes Details
Basis of Presentation (Details)
Net income (loss) per share (Details)
Revenue Recognition (Details)
Revenue Recognition (Details) - Schedule of segment revenue and revenue percentage
Revenue Recognition (Details) - Schedule of Products revenue by geography
Supplemental Disclosure for Statement of Cash Flows (Details)
Inventories (Details) - Schedule of Inventories
Goodwill and intangible assets (Details)
Goodwill and intangible assets (Details) - Schedule of intangible assets all in the life sciences products segment
Goodwill and intangible assets (Details) - Schedule of intangible assets all finite-lived
Goodwill and intangible assets (Details) - Schedule of useful lives for acquisitions
Long term debt (Details)
Long term debt (Details) - Schedule of minimum future annual principal payments
Leases (Details)
Leases (Details) - Schedule of components lease
Leases (Details) - Schedule of lease cost
Leases (Details) - Schedule of lease liability maturity
Leases (Details) - Schedule of lease term and discount rate
Accrued Liabilities (Details)
Accrued Liabilities (Details) - Schedule of accrued liabilities
Stockholders??? Equity (Details)
Stockholders??? Equity (Details) - Schedule of amounts of share-based compensation expense
Stockholders??? Equity (Details) - Schedule of share-based payment arrangement
Stockholders??? Equity (Details) - Schedule of stock option activity
Stockholders??? Equity (Details) - Schedule of nonvested performance-based units activity
Segment reporting (Details)
Segment reporting (Details) - Schedule of financial information represents the operating results of the reportable segments
Contingencies (Details)
Subsequent Events (Details)
Contingencies (Details)
v3.21.2
Contingencies (Details)
3 Months Ended
Oct. 31, 2021
Loss Contingency [Abstract]
Contingencies approval, percent
80.00%
X
- References
No definition available.
+ Details
Name:
enz_ContingenciesApproval
Namespace Prefix:
enz_
Data Type:
dtr:percentItemType
Balance Type:
na
Period Type:
duration
X
- References
No definition available.
+ Details
Name:
us-gaap_LossContingencyAbstract
Namespace Prefix:
us-gaap_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration